Mining Featured Biomarkers Linked with Epithelial Ovarian Cancer Based on Bioinformatics

: Epithelial ovarian cancer (EOC) is the18th most common cancer worldwide and the 8th most common in women. The aim of this study was to diagnose the potential importance of, as well as novel genes linked with, EOC and to provide valid biological information for further research. The gene expression...

Full description

Saved in:
Bibliographic Details
Published in:Diagnostics (Basel) 2019-04, Vol.9 (2), p.39
Main Author: Vastrad, Chanabasayya
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c879-12e6717cad849fb8b5dce7ea463d8240a33373873f0b8fc77cbacfb641181fe23
container_end_page
container_issue 2
container_start_page 39
container_title Diagnostics (Basel)
container_volume 9
creator Vastrad, Chanabasayya
description : Epithelial ovarian cancer (EOC) is the18th most common cancer worldwide and the 8th most common in women. The aim of this study was to diagnose the potential importance of, as well as novel genes linked with, EOC and to provide valid biological information for further research. The gene expression profiles of E-MTAB-3706 which contained four high-grade ovarian epithelial cancer samples, four normal fallopian tube samples and four normal ovarian epithelium samples were downloaded from the ArrayExpress database. Pathway enrichment and Gene Ontology (GO) enrichment analysis of differentially expressed genes (DEGs) were performed, and protein-protein interaction (PPI) network, microRNA-target gene regulatory network and TFs (transcription factors ) -target gene regulatory network for up- and down-regulated were analyzed using Cytoscape. In total, 552 DEGs were found, including 276 up-regulated and 276 down-regulated DEGs. Pathway enrichment analysis demonstrated that most DEGs were significantly enriched in chemical carcinogenesis, urea cycle, cell adhesion molecules and creatine biosynthesis. GO enrichment analysis showed that most DEGs were significantly enriched in translation, nucleosome, extracellular matrix organization and extracellular matrix. From protein-protein interaction network (PPI) analysis, modules, microRNA-target gene regulatory network and TFs-target gene regulatory network for up- and down-regulated, and the top hub genes such as E2F4, SRPK2, A2M, CDH1, MAP1LC3A, UCHL1, HLA-C (major histocompatibility complex, class I, C) , VAT1, ECM1 and SNRPN (small nuclear ribonucleoprotein polypeptide N) were associated in pathogenesis of EOC. The high expression levels of the hub genes such as CEBPD (CCAAT enhancer binding protein delta) and MID2 in stages 3 and 4 were validated in the TCGA (The Cancer Genome Atlas) database. CEBPD andMID2 were associated with the worst overall survival rates in EOC. In conclusion, the current study diagnosed DEGs between normal and EOC samples, which could improve our understanding of the molecular mechanisms in the progression of EOC. These new key biomarkers might be used as therapeutic targets for EOC.
doi_str_mv 10.3390/diagnostics9020039
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_3390_diagnostics9020039</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_3390_diagnostics9020039</sourcerecordid><originalsourceid>FETCH-LOGICAL-c879-12e6717cad849fb8b5dce7ea463d8240a33373873f0b8fc77cbacfb641181fe23</originalsourceid><addsrcrecordid>eNplUEFOwzAQtBBIVKUf4OQPBGyvEztHGrVQqaiXHrhFG8cupqlT2QHE70kEByT2sDsaza5mh5Bbzu4ASnbfejyEPg3epJIJxqC8IDPBVJ5JyfXlH3xNFim9sbFKDlrkM_Ly7IMPB7q2OLxH29Kl708YjzYmuvXhODKffnilq_PYbeexo7sPjB4DrTAYG-kS0yjqw7Tpg-vjCScnN-TKYZfs4nfOyX692ldP2Xb3uKketpnRqsy4sIXiymCrZeka3eStscqiLKDVQjIEAAVagWONdkYp06BxTSE519xZAXMifs6a2KcUravP0Y8PfNWc1VM69f904BsfxFxn</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Mining Featured Biomarkers Linked with Epithelial Ovarian Cancer Based on Bioinformatics</title><source>NCBI_PubMed Central（免费）</source><source>Publicly Available Content Database</source><creator>Vastrad, Chanabasayya</creator><creatorcontrib>Vastrad, Chanabasayya ; Varshita Raju ; Basavaraj Vastrad ; Varun Chandra Alur</creatorcontrib><description>: Epithelial ovarian cancer (EOC) is the18th most common cancer worldwide and the 8th most common in women. The aim of this study was to diagnose the potential importance of, as well as novel genes linked with, EOC and to provide valid biological information for further research. The gene expression profiles of E-MTAB-3706 which contained four high-grade ovarian epithelial cancer samples, four normal fallopian tube samples and four normal ovarian epithelium samples were downloaded from the ArrayExpress database. Pathway enrichment and Gene Ontology (GO) enrichment analysis of differentially expressed genes (DEGs) were performed, and protein-protein interaction (PPI) network, microRNA-target gene regulatory network and TFs (transcription factors ) -target gene regulatory network for up- and down-regulated were analyzed using Cytoscape. In total, 552 DEGs were found, including 276 up-regulated and 276 down-regulated DEGs. Pathway enrichment analysis demonstrated that most DEGs were significantly enriched in chemical carcinogenesis, urea cycle, cell adhesion molecules and creatine biosynthesis. GO enrichment analysis showed that most DEGs were significantly enriched in translation, nucleosome, extracellular matrix organization and extracellular matrix. From protein-protein interaction network (PPI) analysis, modules, microRNA-target gene regulatory network and TFs-target gene regulatory network for up- and down-regulated, and the top hub genes such as E2F4, SRPK2, A2M, CDH1, MAP1LC3A, UCHL1, HLA-C (major histocompatibility complex, class I, C) , VAT1, ECM1 and SNRPN (small nuclear ribonucleoprotein polypeptide N) were associated in pathogenesis of EOC. The high expression levels of the hub genes such as CEBPD (CCAAT enhancer binding protein delta) and MID2 in stages 3 and 4 were validated in the TCGA (The Cancer Genome Atlas) database. CEBPD andMID2 were associated with the worst overall survival rates in EOC. In conclusion, the current study diagnosed DEGs between normal and EOC samples, which could improve our understanding of the molecular mechanisms in the progression of EOC. These new key biomarkers might be used as therapeutic targets for EOC.</description><identifier>ISSN: 2075-4418</identifier><identifier>EISSN: 2075-4418</identifier><identifier>DOI: 10.3390/diagnostics9020039</identifier><language>eng</language><ispartof>Diagnostics (Basel), 2019-04, Vol.9 (2), p.39</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c879-12e6717cad849fb8b5dce7ea463d8240a33373873f0b8fc77cbacfb641181fe23</cites><orcidid>0000-0003-3615-4450</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids></links><search><creatorcontrib>Vastrad, Chanabasayya</creatorcontrib><creatorcontrib>Varshita Raju</creatorcontrib><creatorcontrib>Basavaraj Vastrad</creatorcontrib><creatorcontrib>Varun Chandra Alur</creatorcontrib><title>Mining Featured Biomarkers Linked with Epithelial Ovarian Cancer Based on Bioinformatics</title><title>Diagnostics (Basel)</title><description>: Epithelial ovarian cancer (EOC) is the18th most common cancer worldwide and the 8th most common in women. The aim of this study was to diagnose the potential importance of, as well as novel genes linked with, EOC and to provide valid biological information for further research. The gene expression profiles of E-MTAB-3706 which contained four high-grade ovarian epithelial cancer samples, four normal fallopian tube samples and four normal ovarian epithelium samples were downloaded from the ArrayExpress database. Pathway enrichment and Gene Ontology (GO) enrichment analysis of differentially expressed genes (DEGs) were performed, and protein-protein interaction (PPI) network, microRNA-target gene regulatory network and TFs (transcription factors ) -target gene regulatory network for up- and down-regulated were analyzed using Cytoscape. In total, 552 DEGs were found, including 276 up-regulated and 276 down-regulated DEGs. Pathway enrichment analysis demonstrated that most DEGs were significantly enriched in chemical carcinogenesis, urea cycle, cell adhesion molecules and creatine biosynthesis. GO enrichment analysis showed that most DEGs were significantly enriched in translation, nucleosome, extracellular matrix organization and extracellular matrix. From protein-protein interaction network (PPI) analysis, modules, microRNA-target gene regulatory network and TFs-target gene regulatory network for up- and down-regulated, and the top hub genes such as E2F4, SRPK2, A2M, CDH1, MAP1LC3A, UCHL1, HLA-C (major histocompatibility complex, class I, C) , VAT1, ECM1 and SNRPN (small nuclear ribonucleoprotein polypeptide N) were associated in pathogenesis of EOC. The high expression levels of the hub genes such as CEBPD (CCAAT enhancer binding protein delta) and MID2 in stages 3 and 4 were validated in the TCGA (The Cancer Genome Atlas) database. CEBPD andMID2 were associated with the worst overall survival rates in EOC. In conclusion, the current study diagnosed DEGs between normal and EOC samples, which could improve our understanding of the molecular mechanisms in the progression of EOC. These new key biomarkers might be used as therapeutic targets for EOC.</description><issn>2075-4418</issn><issn>2075-4418</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNplUEFOwzAQtBBIVKUf4OQPBGyvEztHGrVQqaiXHrhFG8cupqlT2QHE70kEByT2sDsaza5mh5Bbzu4ASnbfejyEPg3epJIJxqC8IDPBVJ5JyfXlH3xNFim9sbFKDlrkM_Ly7IMPB7q2OLxH29Kl708YjzYmuvXhODKffnilq_PYbeexo7sPjB4DrTAYG-kS0yjqw7Tpg-vjCScnN-TKYZfs4nfOyX692ldP2Xb3uKketpnRqsy4sIXiymCrZeka3eStscqiLKDVQjIEAAVagWONdkYp06BxTSE519xZAXMifs6a2KcUravP0Y8PfNWc1VM69f904BsfxFxn</recordid><startdate>20190409</startdate><enddate>20190409</enddate><creator>Vastrad, Chanabasayya</creator><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0003-3615-4450</orcidid></search><sort><creationdate>20190409</creationdate><title>Mining Featured Biomarkers Linked with Epithelial Ovarian Cancer Based on Bioinformatics</title><author>Vastrad, Chanabasayya</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c879-12e6717cad849fb8b5dce7ea463d8240a33373873f0b8fc77cbacfb641181fe23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vastrad, Chanabasayya</creatorcontrib><creatorcontrib>Varshita Raju</creatorcontrib><creatorcontrib>Basavaraj Vastrad</creatorcontrib><creatorcontrib>Varun Chandra Alur</creatorcontrib><collection>CrossRef</collection><jtitle>Diagnostics (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vastrad, Chanabasayya</au><aucorp>Varshita Raju</aucorp><aucorp>Basavaraj Vastrad</aucorp><aucorp>Varun Chandra Alur</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mining Featured Biomarkers Linked with Epithelial Ovarian Cancer Based on Bioinformatics</atitle><jtitle>Diagnostics (Basel)</jtitle><date>2019-04-09</date><risdate>2019</risdate><volume>9</volume><issue>2</issue><spage>39</spage><pages>39-</pages><issn>2075-4418</issn><eissn>2075-4418</eissn><abstract>: Epithelial ovarian cancer (EOC) is the18th most common cancer worldwide and the 8th most common in women. The aim of this study was to diagnose the potential importance of, as well as novel genes linked with, EOC and to provide valid biological information for further research. The gene expression profiles of E-MTAB-3706 which contained four high-grade ovarian epithelial cancer samples, four normal fallopian tube samples and four normal ovarian epithelium samples were downloaded from the ArrayExpress database. Pathway enrichment and Gene Ontology (GO) enrichment analysis of differentially expressed genes (DEGs) were performed, and protein-protein interaction (PPI) network, microRNA-target gene regulatory network and TFs (transcription factors ) -target gene regulatory network for up- and down-regulated were analyzed using Cytoscape. In total, 552 DEGs were found, including 276 up-regulated and 276 down-regulated DEGs. Pathway enrichment analysis demonstrated that most DEGs were significantly enriched in chemical carcinogenesis, urea cycle, cell adhesion molecules and creatine biosynthesis. GO enrichment analysis showed that most DEGs were significantly enriched in translation, nucleosome, extracellular matrix organization and extracellular matrix. From protein-protein interaction network (PPI) analysis, modules, microRNA-target gene regulatory network and TFs-target gene regulatory network for up- and down-regulated, and the top hub genes such as E2F4, SRPK2, A2M, CDH1, MAP1LC3A, UCHL1, HLA-C (major histocompatibility complex, class I, C) , VAT1, ECM1 and SNRPN (small nuclear ribonucleoprotein polypeptide N) were associated in pathogenesis of EOC. The high expression levels of the hub genes such as CEBPD (CCAAT enhancer binding protein delta) and MID2 in stages 3 and 4 were validated in the TCGA (The Cancer Genome Atlas) database. CEBPD andMID2 were associated with the worst overall survival rates in EOC. In conclusion, the current study diagnosed DEGs between normal and EOC samples, which could improve our understanding of the molecular mechanisms in the progression of EOC. These new key biomarkers might be used as therapeutic targets for EOC.</abstract><doi>10.3390/diagnostics9020039</doi><orcidid>https://orcid.org/0000-0003-3615-4450</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2075-4418
ispartof Diagnostics (Basel), 2019-04, Vol.9 (2), p.39
issn 2075-4418
2075-4418
language eng
recordid cdi_crossref_primary_10_3390_diagnostics9020039
source NCBI_PubMed Central（免费）; Publicly Available Content Database
title Mining Featured Biomarkers Linked with Epithelial Ovarian Cancer Based on Bioinformatics
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T02%3A35%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mining%20Featured%20Biomarkers%20Linked%20with%20Epithelial%20Ovarian%20Cancer%20Based%20on%20Bioinformatics&rft.jtitle=Diagnostics%20(Basel)&rft.au=Vastrad,%20Chanabasayya&rft.aucorp=Varshita%20Raju&rft.date=2019-04-09&rft.volume=9&rft.issue=2&rft.spage=39&rft.pages=39-&rft.issn=2075-4418&rft.eissn=2075-4418&rft_id=info:doi/10.3390/diagnostics9020039&rft_dat=%3Ccrossref%3E10_3390_diagnostics9020039%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c879-12e6717cad849fb8b5dce7ea463d8240a33373873f0b8fc77cbacfb641181fe23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true